Last checked at 20 Apr 2023 07:00
Cambridge Cognition Holdings Plc
("Cambridge Cognition" or the "Company")
Notice of Results
Cambridge Cognition (AIM: COG), which develops and markets digital solutions to assess brain health, is pleased to confirm that it will announce the Company's preliminary financial results for the year ended 31 December 2022, on Wednesday 3 May 2023.
Enquiries
Cambridge Cognition Holdings Plc Matthew Stork, Chief Executive Officer Stephen Symonds, Chief Financial Officer
| Tel: 012 2381 0700 press@camcog.com |
Panmure Gordon (UK) Limited (NOMAD and Joint Broker) Freddy Crossley / Emma Earl Rupert Dearden
| Tel: 020 7886 2500 (Corporate Finance) (Corporate Broking) |
Dowgate Capital Limited (Joint Broker) David Poutney / James Serjeant
| Tel: 020 3903 7715
|
IFC Advisory Ltd (Financial PR and IR) Tim Metcalfe / Graham Herring / Zach Cohen | Tel: 020 3934 6630 cog@investor-focus.co.uk |
About Cambridge Cognition
Cambridge Cognition is a technology company developing digital health products to better understand, detect and treat conditions affecting brain health. The Company's software products assess cognitive health in patients worldwide to improve clinical trial outcomes, identify and stratify patients early and improve global efficiency in pharmaceutical and healthcare industries.
For further information visit www.cambridgecognition.com